Pub Date : 2025-12-02DOI: 10.1016/j.numecd.2025.104485
Antonio García-Hermoso, Rodrigo Yáñez-Sepúlveda, Ignacio Hormazábal-Aguayo, Jacinto Muñoz-Pardeza, Juan Hurtado-Almonacid, Yasmin Ezzatvar, Mairena Sanchez López, Vicente Martínez-Vizcaíno
Background and aim: Cardiorespiratory fitness, measured as peak oxygen uptake (VO2peak), is a key marker of metabolic health in youth, but age- and sex-specific diagnostic thresholds for identifying elevated cardiometabolic risk (CMR) remain undefined. This study aimed to establish age- and sex-specific VO2peak cut-points for elevated CMR by (i) conducting a cross-sectional diagnostic analysis that compared the diagnostic accuracy of commonly used VO2peak estimation equations (Barnett, Léger, Matsuzaka) to select the best-performing index, and (ii) performing a systematic review and meta-analysis to synthesize and validate findings.
Methods and results: To establish diagnostic thresholds of VO2peak for identifying CMR in youth, we conducted a two-part study. First, a cross-sectional analysis was performed using data from 1059 children aged 8-11 years. Second, a systematic review and meta-analysis were conducted to synthesize evidence from existing observational studies. The literature search included four databases. Eligible studies included cross-sectional or cohort designs with participants aged 3-18 years, and reported cardiorespiratory fitness as VO2peak along with composite measures of CMR. We included 14 studies comprising a total of 20,780 children and adolescents. Optimal VO2peak thresholds for identifying elevated CMR were 43.2 mL/kg/min for boys and 41.9 mL/kg/min for girls aged <13 years, and 40.0 mL/kg/min for boys and 38.5 mL/kg/min for girls aged ≥13. These thresholds demonstrated moderate-to-strong diagnostic performance, and corresponded to the 20th-40th percentiles of international normative data.
Conclusion: We report novel age- and sex-specific VO2peak thresholds for elevated CMR in youth, with good diagnostic performance, to aid early identification and prevention.
{"title":"Diagnostic thresholds of cardiorespiratory fitness for identifying cardiometabolic risk in youth.","authors":"Antonio García-Hermoso, Rodrigo Yáñez-Sepúlveda, Ignacio Hormazábal-Aguayo, Jacinto Muñoz-Pardeza, Juan Hurtado-Almonacid, Yasmin Ezzatvar, Mairena Sanchez López, Vicente Martínez-Vizcaíno","doi":"10.1016/j.numecd.2025.104485","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104485","url":null,"abstract":"<p><strong>Background and aim: </strong>Cardiorespiratory fitness, measured as peak oxygen uptake (VO<sub>2</sub>peak), is a key marker of metabolic health in youth, but age- and sex-specific diagnostic thresholds for identifying elevated cardiometabolic risk (CMR) remain undefined. This study aimed to establish age- and sex-specific VO<sub>2</sub>peak cut-points for elevated CMR by (i) conducting a cross-sectional diagnostic analysis that compared the diagnostic accuracy of commonly used VO<sub>2</sub>peak estimation equations (Barnett, Léger, Matsuzaka) to select the best-performing index, and (ii) performing a systematic review and meta-analysis to synthesize and validate findings.</p><p><strong>Methods and results: </strong>To establish diagnostic thresholds of VO<sub>2</sub>peak for identifying CMR in youth, we conducted a two-part study. First, a cross-sectional analysis was performed using data from 1059 children aged 8-11 years. Second, a systematic review and meta-analysis were conducted to synthesize evidence from existing observational studies. The literature search included four databases. Eligible studies included cross-sectional or cohort designs with participants aged 3-18 years, and reported cardiorespiratory fitness as VO<sub>2</sub>peak along with composite measures of CMR. We included 14 studies comprising a total of 20,780 children and adolescents. Optimal VO<sub>2</sub>peak thresholds for identifying elevated CMR were 43.2 mL/kg/min for boys and 41.9 mL/kg/min for girls aged <13 years, and 40.0 mL/kg/min for boys and 38.5 mL/kg/min for girls aged ≥13. These thresholds demonstrated moderate-to-strong diagnostic performance, and corresponded to the 20th-40th percentiles of international normative data.</p><p><strong>Conclusion: </strong>We report novel age- and sex-specific VO<sub>2</sub>peak thresholds for elevated CMR in youth, with good diagnostic performance, to aid early identification and prevention.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104485"},"PeriodicalIF":3.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1016/j.numecd.2025.104487
Jumana Abuqwider, Edoardo Pasolli, Giuseppe Scidà, Alessandra Corrado, Marilena Vitale, Francesca De Filippis, Danilo Ercolini, Giovanni Annuzzi, Angela A Rivellese, Lutgarda Bozzetto
Background and aims: The Mediterranean diet (MD) has been associated with better glycaemic control in children with type 1 diabetes mellitus (T1DM) and favourable microbiome profiles in healthy individuals. However, it remains unclear whether MD adherence is associated with glycaemic control via microbiome. This study examined the relationships among MD adherence, gut microbiome, and glycaemic control in adults with T1DM and assessed the microbiome's ability to predict clinical and dietary outcomes.
Methods and results: In a cross-sectional study of 253 adults with T1DM, dietary intake was assessed using the EPIC food frequency questionnaire, and MD adherence was measured using the rMED score. Participants were stratified by adherence level (low, medium, high). Glycaemic control was evaluated using HbA1c and CGM metrics. Shotgun metagenomic sequencing of stool samples (n = 103) assessed the gut microbiome. Statistical analyses included ANOVA, PERMANOVA, LEfSe, and machine learning modeling. Higher MD adherence was associated with lower HbA1c levels (7.1 % vs 7.7 %; p < 0.001), greater time in range (67.0 % vs 59.4 %; p-trend = 0.03), and higher HDL cholesterol (1.62 vs 1.39 mmol/L; p = 0.01). High MD adherence was linked to a greater abundance of bacterial species such as Faecalibacterium prausnitzii. Both high MD adherence and lower HbA1c were associated with distinct microbiome functional pathways. Microbiome-based machine learning models predicted dietary patterns and clinical metrics.
Conclusions: In adults with T1DM, greater MD adherence is associated with better glycaemic control and a favourable gut microbiome. Specific microbial pathways may underlie these associations. Integrating diet and microbiome data supports personalized care. The study was registered at ClinicalTrials.gov with the identifier NCT05936242.
背景和目的:地中海饮食(MD)与1型糖尿病儿童(T1DM)更好的血糖控制和健康个体有利的微生物群谱有关。然而,目前尚不清楚MD依从性是否与微生物组的血糖控制有关。本研究检查了糖尿病成人患者的MD依从性、肠道微生物组和血糖控制之间的关系,并评估了微生物组预测临床和饮食结果的能力。方法和结果:在一项253名成年T1DM患者的横断面研究中,使用EPIC食物频率问卷评估饮食摄入量,使用rMED评分测量MD依从性。参与者按依从程度(低、中、高)分层。使用HbA1c和CGM指标评估血糖控制情况。粪便样本(n = 103)的霰弹枪宏基因组测序评估肠道微生物组。统计分析包括ANOVA、PERMANOVA、LEfSe和机器学习建模。较高的MD依从性与较低的HbA1c水平相关(7.1% vs 7.7%; p)结论:在成人T1DM患者中,较高的MD依从性与更好的血糖控制和有利的肠道微生物群相关。特定的微生物途径可能是这些关联的基础。整合饮食和微生物组数据支持个性化护理。该研究已在ClinicalTrials.gov注册,识别码为NCT05936242。
{"title":"Gut microbiome profiles and associated functional pathways are linked to Mediterranean diet adherence and blood glucose control in adults with type 1 diabetes mellitus.","authors":"Jumana Abuqwider, Edoardo Pasolli, Giuseppe Scidà, Alessandra Corrado, Marilena Vitale, Francesca De Filippis, Danilo Ercolini, Giovanni Annuzzi, Angela A Rivellese, Lutgarda Bozzetto","doi":"10.1016/j.numecd.2025.104487","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104487","url":null,"abstract":"<p><strong>Background and aims: </strong>The Mediterranean diet (MD) has been associated with better glycaemic control in children with type 1 diabetes mellitus (T1DM) and favourable microbiome profiles in healthy individuals. However, it remains unclear whether MD adherence is associated with glycaemic control via microbiome. This study examined the relationships among MD adherence, gut microbiome, and glycaemic control in adults with T1DM and assessed the microbiome's ability to predict clinical and dietary outcomes.</p><p><strong>Methods and results: </strong>In a cross-sectional study of 253 adults with T1DM, dietary intake was assessed using the EPIC food frequency questionnaire, and MD adherence was measured using the rMED score. Participants were stratified by adherence level (low, medium, high). Glycaemic control was evaluated using HbA1c and CGM metrics. Shotgun metagenomic sequencing of stool samples (n = 103) assessed the gut microbiome. Statistical analyses included ANOVA, PERMANOVA, LEfSe, and machine learning modeling. Higher MD adherence was associated with lower HbA1c levels (7.1 % vs 7.7 %; p < 0.001), greater time in range (67.0 % vs 59.4 %; p-trend = 0.03), and higher HDL cholesterol (1.62 vs 1.39 mmol/L; p = 0.01). High MD adherence was linked to a greater abundance of bacterial species such as Faecalibacterium prausnitzii. Both high MD adherence and lower HbA1c were associated with distinct microbiome functional pathways. Microbiome-based machine learning models predicted dietary patterns and clinical metrics.</p><p><strong>Conclusions: </strong>In adults with T1DM, greater MD adherence is associated with better glycaemic control and a favourable gut microbiome. Specific microbial pathways may underlie these associations. Integrating diet and microbiome data supports personalized care. The study was registered at ClinicalTrials.gov with the identifier NCT05936242.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104487"},"PeriodicalIF":3.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145897066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.numecd.2025.104484
Van H Nguyen, Leticia Radin Pereira, Oliver M Shannon, Blossom Cm Stephan, Mario Siervo
The integrity of the vascular endothelium is fundamental to regulating cardio-metabolic and neurological functions. Endothelial dysfunction (ED) is a key driver of atherosclerosis and is strongly linked to the pathogenesis of heart disease, peripheral arterial disease, and stroke. This review describes the relationship between dietary patterns and endothelial health, focusing on observational and experimental studies that investigate the protective effects of healthy dietary patterns in the maintenance of endothelial integrity and prevention of ED. Plant-based diets, including Mediterranean and Dietary Approaches to Stop Hypertension (DASH) dietary patterns, have been linked to improvement of endothelial function through multiple mechanisms such as increased nitric oxide bioavailability, reduced oxidative stress and inflammation, and fostering a healthy gut microbiome. Traditional Japanese, Nordic, and Palaeolithic dietary patterns also show potential cardiovascular benefits through improved vascular biomarkers and significant anti-inflammatory effects, though evidence on effects on endothelial function remains less established. The consequences of poor endothelial health extend to all systems, and the brain is one of the organs crucially affected by ED. ED has been increasingly recognised as a critical contributor to cognitive decline, dementia, and stroke, largely accounted and explained by mechanisms impairing cerebral blood flow, neuronal metabolism, neuro-vascular coupling and compromised integrity of the blood-brain barrier. This review highlights the importance of maintaining endothelial health as a protective strategy for cognitive function and reduction of dementia risk. Adherence to dietary patterns with protective effects on endothelial integrity may represent an effective strategy to promote lifelong health for both the heart and brain.
{"title":"Dietary patterns and endothelium dysfunction: a literature review.","authors":"Van H Nguyen, Leticia Radin Pereira, Oliver M Shannon, Blossom Cm Stephan, Mario Siervo","doi":"10.1016/j.numecd.2025.104484","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104484","url":null,"abstract":"<p><p>The integrity of the vascular endothelium is fundamental to regulating cardio-metabolic and neurological functions. Endothelial dysfunction (ED) is a key driver of atherosclerosis and is strongly linked to the pathogenesis of heart disease, peripheral arterial disease, and stroke. This review describes the relationship between dietary patterns and endothelial health, focusing on observational and experimental studies that investigate the protective effects of healthy dietary patterns in the maintenance of endothelial integrity and prevention of ED. Plant-based diets, including Mediterranean and Dietary Approaches to Stop Hypertension (DASH) dietary patterns, have been linked to improvement of endothelial function through multiple mechanisms such as increased nitric oxide bioavailability, reduced oxidative stress and inflammation, and fostering a healthy gut microbiome. Traditional Japanese, Nordic, and Palaeolithic dietary patterns also show potential cardiovascular benefits through improved vascular biomarkers and significant anti-inflammatory effects, though evidence on effects on endothelial function remains less established. The consequences of poor endothelial health extend to all systems, and the brain is one of the organs crucially affected by ED. ED has been increasingly recognised as a critical contributor to cognitive decline, dementia, and stroke, largely accounted and explained by mechanisms impairing cerebral blood flow, neuronal metabolism, neuro-vascular coupling and compromised integrity of the blood-brain barrier. This review highlights the importance of maintaining endothelial health as a protective strategy for cognitive function and reduction of dementia risk. Adherence to dietary patterns with protective effects on endothelial integrity may represent an effective strategy to promote lifelong health for both the heart and brain.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104484"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.numecd.2025.104478
Claudia R L Cardoso, Cristiane A Villela-Nogueira, Gil F Salles, Nathalie C Leite
Background and aim: Reduction in liver fibrosis, as assessed by liver stiffness measurement (LSM) on serial vibration-controlled transient elastography (VCTE) examinations, may have beneficial effects on development of liver-related and cardiovascular outcomes in individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD).
Methods and results: A prospective cohort of 288 individuals with type 2 diabetes and MASLD performed 2 VCTE exams at least two years apart, and significant LSM reduction was defined as >20 % decrease. Logistic regression assessed the independent correlates of having LSM reduction and multivariable Cox analyses assessed associations between LSM reduction and liver-related and cardiovascular outcomes. Eighty-six individuals (30 %) had a reduction in LSM >20 %; its independent correlates were a lower aspartate aminotransferase (AST ≤20 U/L) and HbA1c (≤7 %) levels closest to the 2nd VCTE exam, the use of statins and having the wild CC genotype of the PNPLA3 gene. Over a median follow-up of 6 years, there were 22 liver-related and 28 cardiovascular events. Reduction in LSM was associated with a significant 78 % lower risk of liver events and 62 % lower cardiovascular risk.
Conclusions: Using statins and achieving good glycemic control are associated with higher chances of having liver fibrosis reduction, and serum AST reduction may be a biomarker of such improvement. Having LSM reduction on serial VCTE examinations is associated with lower risks of adverse cardiovascular and liver-related events and, if further confirmed, it might be a treatment goal in individuals with type 2 diabetes and MASLD.
{"title":"Correlated factors and prognostic importance of reduction in liver stiffness measurement in individuals with type 2 diabetes and MASLD.","authors":"Claudia R L Cardoso, Cristiane A Villela-Nogueira, Gil F Salles, Nathalie C Leite","doi":"10.1016/j.numecd.2025.104478","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104478","url":null,"abstract":"<p><strong>Background and aim: </strong>Reduction in liver fibrosis, as assessed by liver stiffness measurement (LSM) on serial vibration-controlled transient elastography (VCTE) examinations, may have beneficial effects on development of liver-related and cardiovascular outcomes in individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD).</p><p><strong>Methods and results: </strong>A prospective cohort of 288 individuals with type 2 diabetes and MASLD performed 2 VCTE exams at least two years apart, and significant LSM reduction was defined as >20 % decrease. Logistic regression assessed the independent correlates of having LSM reduction and multivariable Cox analyses assessed associations between LSM reduction and liver-related and cardiovascular outcomes. Eighty-six individuals (30 %) had a reduction in LSM >20 %; its independent correlates were a lower aspartate aminotransferase (AST ≤20 U/L) and HbA<sub>1c</sub> (≤7 %) levels closest to the 2nd VCTE exam, the use of statins and having the wild CC genotype of the PNPLA3 gene. Over a median follow-up of 6 years, there were 22 liver-related and 28 cardiovascular events. Reduction in LSM was associated with a significant 78 % lower risk of liver events and 62 % lower cardiovascular risk.</p><p><strong>Conclusions: </strong>Using statins and achieving good glycemic control are associated with higher chances of having liver fibrosis reduction, and serum AST reduction may be a biomarker of such improvement. Having LSM reduction on serial VCTE examinations is associated with lower risks of adverse cardiovascular and liver-related events and, if further confirmed, it might be a treatment goal in individuals with type 2 diabetes and MASLD.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104478"},"PeriodicalIF":3.7,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.numecd.2025.104480
Chutharat Thanchonnang, Schawanya K Rattanapitoon, Patpicha Arunsan, Nathkapach K Rattanapitoon
{"title":"Reframing the drivers of obesity: Integrating commercial determinants and metabolic diversity into post-pharmacotherapy strategies.","authors":"Chutharat Thanchonnang, Schawanya K Rattanapitoon, Patpicha Arunsan, Nathkapach K Rattanapitoon","doi":"10.1016/j.numecd.2025.104480","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104480","url":null,"abstract":"","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104480"},"PeriodicalIF":3.7,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.numecd.2025.104476
Noreen Z Siddiqui, Joline W J Beulens, Jaime E Hart, Jochem O Klompmaker, Joreintje D Mackenbach, Maria G M Pinho, Eric B Rimm, Peter James
Background and aims: Inflammation is an established cardiovascular disease risk factor, but its role in the link between food environments and cardiovascular risk remains unexplored. We aimed to study longitudinal associations between residential fast food outlets (FFOs) and inflammatory markers in US females from the Nurses' Health Study II with stored blood and residential addresses.
Methods and results: We counted FFOs within 1500-m buffers around each address in 1998 and 2010. In samples collected at two time points (1999, 2011), we measured C-reactive protein (CRP, N = 1350), Interleukin-6 (IL-6, N = 809), and adiponectin (N = 836). We performed multivariable linear regression with repeated measures to study changes in FFOs and inflammatory markers and multivariable linear regression analyses to study FFOs count in 1998 and changes in inflammatory markers between 1999 and 2011. Models were adjusted for age, race/ethnicity, partners' education, smoking, neighborhood socioeconomic status (nSES), and population density. We explored effect modification by nSES and population density. No associations were observed in linear mixed models (e.g., CRP (β: 0.00, 95 %CI: 0.01,0.01) or in linear models including changes in inflammatory outcomes (e.g., CRP (β:0.00, 95 %CI: 0.01, 0.02). We also observed no effect modification for nSES or population density.
Conclusion: In conclusion, we found no evidence for longitudinal associations between FFOs count and inflammatory markers in this study.
背景和目的:炎症是一种确定的心血管疾病危险因素,但其在食物环境和心血管风险之间的联系中的作用仍未被探索。我们的目的是研究住宅快餐店(ffo)与美国女性炎症标志物之间的纵向关联,这些女性来自护士健康研究II,储存血液和居住地址。方法与结果:我们在1998年和2010年对每个地址周围1500米缓冲区内的ffo进行了统计。在两个时间点(1999年、2011年)采集的样本中,我们测量了c反应蛋白(CRP, N = 1350)、白细胞介素-6 (IL-6, N = 809)和脂联素(N = 836)。我们采用重复测量的多变量线性回归来研究ffo和炎症标志物的变化,并采用多变量线性回归分析来研究1998年ffo计数和1999年至2011年炎症标志物的变化。模型根据年龄、种族/民族、伴侣教育程度、吸烟、社区社会经济地位(nSES)和人口密度进行了调整。研究了nSES和人口密度对效应的影响。在线性混合模型(例如,CRP (β:0.00, 95% CI: 0.01,0.01)或包括炎症结果变化的线性模型(例如,CRP (β:0.00, 95% CI: 0.01, 0.02)中未观察到相关性。我们也没有观察到nSES或种群密度的效应改变。结论:在本研究中,我们没有发现ffo计数与炎症标志物之间存在纵向关联的证据。
{"title":"Longitudinal associations between fast food outlet count and inflammatory markers in the US-based nurses' health study II between 1998 and 2011.","authors":"Noreen Z Siddiqui, Joline W J Beulens, Jaime E Hart, Jochem O Klompmaker, Joreintje D Mackenbach, Maria G M Pinho, Eric B Rimm, Peter James","doi":"10.1016/j.numecd.2025.104476","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104476","url":null,"abstract":"<p><strong>Background and aims: </strong>Inflammation is an established cardiovascular disease risk factor, but its role in the link between food environments and cardiovascular risk remains unexplored. We aimed to study longitudinal associations between residential fast food outlets (FFOs) and inflammatory markers in US females from the Nurses' Health Study II with stored blood and residential addresses.</p><p><strong>Methods and results: </strong>We counted FFOs within 1500-m buffers around each address in 1998 and 2010. In samples collected at two time points (1999, 2011), we measured C-reactive protein (CRP, N = 1350), Interleukin-6 (IL-6, N = 809), and adiponectin (N = 836). We performed multivariable linear regression with repeated measures to study changes in FFOs and inflammatory markers and multivariable linear regression analyses to study FFOs count in 1998 and changes in inflammatory markers between 1999 and 2011. Models were adjusted for age, race/ethnicity, partners' education, smoking, neighborhood socioeconomic status (nSES), and population density. We explored effect modification by nSES and population density. No associations were observed in linear mixed models (e.g., CRP (β: 0.00, 95 %CI: 0.01,0.01) or in linear models including changes in inflammatory outcomes (e.g., CRP (β:0.00, 95 %CI: 0.01, 0.02). We also observed no effect modification for nSES or population density.</p><p><strong>Conclusion: </strong>In conclusion, we found no evidence for longitudinal associations between FFOs count and inflammatory markers in this study.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104476"},"PeriodicalIF":3.7,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.numecd.2025.104475
Setor K Kunutsor, Atanu Bhattacharjee, Sae Young Jae, Jari A Laukkanen
Background and aims: Evidence on the association of Body Roundness Index (BRI), an anthropometric indicator of body fat and visceral adiposity, with cardiometabolic multimorbidity (CMM) remains limited. This study aimed to compare the associations and predictive utilities of BRI and body mass index (BMI) for CMM.
Methods and results: We analyzed data from 3348 adults (mean age 63 years; 45.1 % male) in the English Longitudinal Study of Ageing, free of major cardiometabolic conditions at baseline (2008-2009). BRI was derived from height and waist circumference. CMM was defined as having ≥2 of the following by 2021-2023: hypertension, cardiovascular disease, diabetes, or stroke. Multivariable odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated. During 12-15 years of follow-up, 197 participants (5.9 %) developed CMM. Both BRI and BMI showed linear dose-response relationships with CMM risk (p for nonlinearity >0.05). Higher BRI was associated with increased odds of CMM (per 1-SD: OR 1.33, 95 % CI 1.17-1.53; top vs bottom tertile: OR 1.89, 95 % CI 1.23-2.90), with similar findings for BMI. Adding BRI to conventional risk models modestly improved discrimination (ΔC-index = 0.0082, p = .26) and significantly improved model fit (p < .001). Gains for BMI were smaller (ΔC-index = 0.0049, p = .46), with BRI offering a slightly greater improvement in predictive performance (Δ = 0.0033, p = .40).
Conclusion: Both BRI and BMI were independently and linearly associated with an increased risk of CMM. BRI showed slightly stronger predictive performance than BMI.
背景和目的:身体圆度指数(BRI)是身体脂肪和内脏脂肪的人体测量指标,与心脏代谢多病(CMM)的关联证据仍然有限。本研究旨在比较BRI和身体质量指数(BMI)对CMM的相关性和预测效用。方法和结果:我们分析了英国老龄化纵向研究中3348名成年人(平均年龄63岁,45.1%为男性)的数据,在基线时无主要心脏代谢疾病(2008-2009)。BRI来源于身高和腰围。到2021-2023年,CMM被定义为具有以下≥2项:高血压、心血管疾病、糖尿病或中风。估计了多变量优势比(ORs)和95%置信区间(ci)。在12-15年的随访中,197名参与者(5.9%)发展为CMM。BRI和BMI与CMM风险呈线性剂量-反应关系(p为非线性,p < 0.05)。较高的BRI与CMM的几率增加相关(每1-SD: OR 1.33, 95% CI 1.17-1.53;顶部与底部分位:OR 1.89, 95% CI 1.23-2.90), BMI也有类似的发现。在传统的风险模型中加入BRI可以适度改善识别(ΔC-index = 0.0082, p = 0.26),并显著改善模型拟合(p)。结论:BRI和BMI与CMM风险增加独立且线性相关。BRI的预测性能略强于BMI。
{"title":"Body roundness index and cardiometabolic multimorbidity: Findings from the English Longitudinal Study of Ageing.","authors":"Setor K Kunutsor, Atanu Bhattacharjee, Sae Young Jae, Jari A Laukkanen","doi":"10.1016/j.numecd.2025.104475","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104475","url":null,"abstract":"<p><strong>Background and aims: </strong>Evidence on the association of Body Roundness Index (BRI), an anthropometric indicator of body fat and visceral adiposity, with cardiometabolic multimorbidity (CMM) remains limited. This study aimed to compare the associations and predictive utilities of BRI and body mass index (BMI) for CMM.</p><p><strong>Methods and results: </strong>We analyzed data from 3348 adults (mean age 63 years; 45.1 % male) in the English Longitudinal Study of Ageing, free of major cardiometabolic conditions at baseline (2008-2009). BRI was derived from height and waist circumference. CMM was defined as having ≥2 of the following by 2021-2023: hypertension, cardiovascular disease, diabetes, or stroke. Multivariable odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated. During 12-15 years of follow-up, 197 participants (5.9 %) developed CMM. Both BRI and BMI showed linear dose-response relationships with CMM risk (p for nonlinearity >0.05). Higher BRI was associated with increased odds of CMM (per 1-SD: OR 1.33, 95 % CI 1.17-1.53; top vs bottom tertile: OR 1.89, 95 % CI 1.23-2.90), with similar findings for BMI. Adding BRI to conventional risk models modestly improved discrimination (ΔC-index = 0.0082, p = .26) and significantly improved model fit (p < .001). Gains for BMI were smaller (ΔC-index = 0.0049, p = .46), with BRI offering a slightly greater improvement in predictive performance (Δ = 0.0033, p = .40).</p><p><strong>Conclusion: </strong>Both BRI and BMI were independently and linearly associated with an increased risk of CMM. BRI showed slightly stronger predictive performance than BMI.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104475"},"PeriodicalIF":3.7,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.numecd.2025.104474
Aihong Wan, Yuqin Han, Lingling Wu, Yuanhao Wei, Xiqiao Xiang, Yi Chen, Jinquan Chen, Aihua Song, Kun Zhao
Background and aims: Previous studies have suggested links between the triglycerides to high-density lipoprotein cholesterol (TG:HDL-C) ratio on blood pressure (BP) traits and hypertension (HTN) risk. However, the causal relationships remain unclear.
Methods and results: We conducted genome-wide linkage disequilibrium score regression (LDSC), two-sample Mendelian randomization (MR), colocalization, reverse, and multivariable MR (MVMR) analyses to evaluate the causal relationships between the TG:HDL-C ratio and BP traits. BP traits (systolic BP [SBP], diastolic BP [DBP], and pulse pressure [PP]) were obtained from the International Consortium for Blood Pressure and UK Biobank. HTN data were from GWAS meta-analyses. The primary analysis used the inverse variance method (IVW), with sensitivity analyses for MR. Significant genetic correlations were found between the TG:HDL-C ratio and BP traits (all P values < 0.05). Genetically predicted TG:HDL-C ratio was associated with increased SBP (β = 1.194, 95 % CI: 1.007-1.382), DBP (β = 0.680, 95 % CI: 0.553-0.807), and PP (β = 0.469, 95 % CI: 0.359-0.579). It also increased HTN risk (OR = 1.030, 95 % CI: 1.025-1.036, discovery; OR = 1.169, 95 % CI: 1.138-1.200, replication; OR = 1.089, 95 % CI: 1.049-1.131, meta-analysis). MVMR showed persistent causal relationships with DBP (β = 0.219, 95 % CI: 0.072-0.366) and HTN (OR = 1.010, 95 % CI: 1.005-1.015, discovery; OR = 1.055, 95 % CI: 1.024-1.086, replication). Colocalization analysis supported shared genetic architecture. Sensitivity analyses confirmed robustness.
Conclusions: Our study provides genetic evidence that the TG:HDL-C ratio is causally related to DBP and HTN. These findings were consistent across robust MR methods. However, no independent causal relationship was observed between the TG:HDL-C ratio and SBP or PP after lipid adjustment in MVMR. Further interventional studies are needed.
{"title":"Novel insights into the causal effects of triglycerides to high density lipoprotein cholesterol ratio on blood pressure.","authors":"Aihong Wan, Yuqin Han, Lingling Wu, Yuanhao Wei, Xiqiao Xiang, Yi Chen, Jinquan Chen, Aihua Song, Kun Zhao","doi":"10.1016/j.numecd.2025.104474","DOIUrl":"https://doi.org/10.1016/j.numecd.2025.104474","url":null,"abstract":"<p><strong>Background and aims: </strong>Previous studies have suggested links between the triglycerides to high-density lipoprotein cholesterol (TG:HDL-C) ratio on blood pressure (BP) traits and hypertension (HTN) risk. However, the causal relationships remain unclear.</p><p><strong>Methods and results: </strong>We conducted genome-wide linkage disequilibrium score regression (LDSC), two-sample Mendelian randomization (MR), colocalization, reverse, and multivariable MR (MVMR) analyses to evaluate the causal relationships between the TG:HDL-C ratio and BP traits. BP traits (systolic BP [SBP], diastolic BP [DBP], and pulse pressure [PP]) were obtained from the International Consortium for Blood Pressure and UK Biobank. HTN data were from GWAS meta-analyses. The primary analysis used the inverse variance method (IVW), with sensitivity analyses for MR. Significant genetic correlations were found between the TG:HDL-C ratio and BP traits (all P values < 0.05). Genetically predicted TG:HDL-C ratio was associated with increased SBP (β = 1.194, 95 % CI: 1.007-1.382), DBP (β = 0.680, 95 % CI: 0.553-0.807), and PP (β = 0.469, 95 % CI: 0.359-0.579). It also increased HTN risk (OR = 1.030, 95 % CI: 1.025-1.036, discovery; OR = 1.169, 95 % CI: 1.138-1.200, replication; OR = 1.089, 95 % CI: 1.049-1.131, meta-analysis). MVMR showed persistent causal relationships with DBP (β = 0.219, 95 % CI: 0.072-0.366) and HTN (OR = 1.010, 95 % CI: 1.005-1.015, discovery; OR = 1.055, 95 % CI: 1.024-1.086, replication). Colocalization analysis supported shared genetic architecture. Sensitivity analyses confirmed robustness.</p><p><strong>Conclusions: </strong>Our study provides genetic evidence that the TG:HDL-C ratio is causally related to DBP and HTN. These findings were consistent across robust MR methods. However, no independent causal relationship was observed between the TG:HDL-C ratio and SBP or PP after lipid adjustment in MVMR. Further interventional studies are needed.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":"104474"},"PeriodicalIF":3.7,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145897079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-21DOI: 10.1016/j.numecd.2025.104472
Joanna Popiolek-Kalisz , Adrian Kwasny
Aims
Cardiovascular diseases are the leading cause of mortality worldwide with lipid disorders as one of the main modifiable risk factors. Lifestyle modification, including dietary approach, is crucial for dyslipidemia management. Intermittent fasting (IF), with its various regimens, has gained attention as a potential strategy to improve lipid parameters. This umbrella review evaluates recent evidence from meta-analyses regarding the impact of IF, including time-restricted eating (TRE), alternate-day fasting (ADF), and Ramadan intermittent fasting (RIF), on lipid profile parameters such as total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG).
Data synthesis
A systematic search of PubMed, Scopus, and Web of Science databases was conducted for meta-analyses published between 2020 and 2025. The inclusion criteria were human studies, IF interventions of any type, and outcomes presenting abovementioned lipid profile parameters. Fifty-seven meta-analyses met the inclusion criteria. The evidence suggests that TRE may modestly reduce TG levels, particularly in overweight individuals, with a limited impact on LDL-C, HDL-C, and TC. ADF demonstrated inconsistent effects on lipid profile. RIF presented modest improvements of TG and HDL-C. Heterogeneity of study designs, fasting regimens and durations, and control groups limited the interpretation of potential findings.
Conclusions
IF appears to present modest benefits on lipid profile, mainly in TG reduction, while data on LDL-C, HDL-C, and TC remains inconsistent. Among IF regimens, TRE demonstrates greater potential benefits, particularly when combined with caloric restriction. However, significant heterogeneity across meta-analyses and short follow-up durations hinders providing definitive conclusions. Future research should prioritize standardization of IF protocols, extended study durations, and consistent comparator groups to clarify the clinical relevance of IF in dyslipidemia management.
目的:心血管疾病是世界范围内死亡的主要原因,脂质紊乱是主要可改变的危险因素之一。生活方式的改变,包括饮食方法,对血脂异常的管理至关重要。间歇性禁食(IF)作为一种改善血脂参数的潜在策略,其各种方案已引起人们的关注。本综述评估了近期关于IF影响的荟萃分析证据,包括限时饮食(TRE)、隔日禁食(ADF)和斋月间歇性禁食(RIF),对血脂参数如总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和甘油三酯(TG)的影响。数据综合:系统检索PubMed、Scopus和Web of Science数据库,检索2020年至2025年间发表的meta分析。纳入标准为人体研究、任何类型的IF干预以及呈现上述血脂参数的结果。57项荟萃分析符合纳入标准。有证据表明,TRE可以适度降低TG水平,特别是在超重个体中,对LDL-C, HDL-C和TC的影响有限。ADF对血脂的影响不一致。RIF可适度改善TG和HDL-C。研究设计、禁食方案和持续时间以及对照组的异质性限制了对潜在发现的解释。结论:IF似乎对血脂有一定的益处,主要是TG的降低,而LDL-C、HDL-C和TC的数据仍然不一致。在IF方案中,TRE显示出更大的潜在益处,特别是与热量限制相结合时。然而,meta分析的显著异质性和较短的随访时间阻碍了提供明确的结论。未来的研究应优先考虑IF方案的标准化、延长研究时间和一致的比较组,以阐明IF在血脂异常管理中的临床相关性。
{"title":"The impact of intermittent fasting on lipid profile – an umbrella review","authors":"Joanna Popiolek-Kalisz , Adrian Kwasny","doi":"10.1016/j.numecd.2025.104472","DOIUrl":"10.1016/j.numecd.2025.104472","url":null,"abstract":"<div><h3>Aims</h3><div>Cardiovascular diseases are the leading cause of mortality worldwide with lipid disorders as one of the main modifiable risk factors. Lifestyle modification, including dietary approach, is crucial for dyslipidemia management. Intermittent fasting (IF), with its various regimens, has gained attention as a potential strategy to improve lipid parameters. This umbrella review evaluates recent evidence from meta-analyses regarding the impact of IF, including time-restricted eating (TRE), alternate-day fasting (ADF), and Ramadan intermittent fasting (RIF), on lipid profile parameters such as total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG).</div></div><div><h3>Data synthesis</h3><div>A systematic search of PubMed, Scopus, and Web of Science databases was conducted for meta-analyses published between 2020 and 2025. The inclusion criteria were human studies, IF interventions of any type, and outcomes presenting abovementioned lipid profile parameters. Fifty-seven meta-analyses met the inclusion criteria. The evidence suggests that TRE may modestly reduce TG levels, particularly in overweight individuals, with a limited impact on LDL-C, HDL-C, and TC. ADF demonstrated inconsistent effects on lipid profile. RIF presented modest improvements of TG and HDL-C. Heterogeneity of study designs, fasting regimens and durations, and control groups limited the interpretation of potential findings.</div></div><div><h3>Conclusions</h3><div>IF appears to present modest benefits on lipid profile, mainly in TG reduction, while data on LDL-C, HDL-C, and TC remains inconsistent. Among IF regimens, TRE demonstrates greater potential benefits, particularly when combined with caloric restriction. However, significant heterogeneity across meta-analyses and short follow-up durations hinders providing definitive conclusions. Future research should prioritize standardization of IF protocols, extended study durations, and consistent comparator groups to clarify the clinical relevance of IF in dyslipidemia management.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":"36 3","pages":"Article 104472"},"PeriodicalIF":3.7,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}